Platelet-Rich Plasma and Its Analogs Do Not Clinically Improve Functional Outcomes 1 Year After Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2026;14(8):3 Arthroscopy. 2025 01-Dec;():. 10.1016/j.arthro.2025.06.031Study Summary
Nine studies including 502 patients undergoing anterior cruciate ligament (ACL) reconstruction were included in this systematic review and meta-analysis comparing platelet-rich plasma (PRP) versus no PRP. Pooled outcomes of interest included International Knee Documentation Committee (IKDC) score, Lysholm score, and Tegner activity score at 12 months. PRP demonstrated a statistically significant improvement in IKDC score, but did not reach the minimal clinically important difference, and no significant differences were observed in Lysholm or Tegner scores. Overall, PRP did not provide clinically meaningful functional improvement at 1 year following ACL reconstruction.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!